24 HR naproxen 375 MG Extended Release Oral Tablet
naproxen
RxCUI: 1116320
What the CMS Formulary Data Shows for 24 HR naproxen 375 MG Extended Release Oral Tablet
Per the CMS 2026 Part D formulary file, 24 HR naproxen 375 MG Extended Release Oral Tablet (RxNorm concept RXCUI 1116320, generic name naproxen) appears on 2 distinct formulary files spanning 7 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.5.
Real-world access to 24 HR naproxen 375 MG Extended Release Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 24 HR naproxen 375 MG Extended Release Oral Tablet today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 7
- Coverage rate
- 0.1%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 24 HR naproxen 375 MG Extended Release Oral Tablet
7 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CareAdvantage (HMO D-SNP) | SAN MATEO HEALTH COMMISSION | T1 | No | $0 | CA |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | No | $47.00 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | No | $59.70 | PA |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | No | $63.50 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | No | $79.70 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T4 | No | $102.20 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T4 | No | $112.70 | PA |
Frequently Asked Questions
Is 24 HR naproxen 375 MG Extended Release Oral Tablet covered by Medicare Part D?
Yes, 24 HR naproxen 375 MG Extended Release Oral Tablet is covered by 7 Medicare Part D plans (0.1% of all Part D formularies).
What tier is 24 HR naproxen 375 MG Extended Release Oral Tablet on Medicare Part D plans?
24 HR naproxen 375 MG Extended Release Oral Tablet averages Tier 2.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does 24 HR naproxen 375 MG Extended Release Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for 24 HR naproxen 375 MG Extended Release Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
Read our methodology - how this data is sourced, computed, and verified.